Job Recruitment Website - Job seeking and recruitment - How about Hebi Branch of Sinopharm Holding Henan Co., Ltd.?

How about Hebi Branch of Sinopharm Holding Henan Co., Ltd.?

Hebi Branch of Sinopharm Holding Henan Co., Ltd. is a branch of 2018-02-1other joint-stock companies (unlisted) registered in qibin district, Hebi City, Henan Province, with registered addresses at Huijin Building, Qibin Avenue, qibin district, Hebi City 106, 107 and 65438.

The unified social credit code/registration number of Hebi Branch of Sinopharm Holding Henan Co., Ltd. is 914161ma44wrbw87, and the enterprise is in the opening state.

The business scope of Hebi Branch of Sinopharm Holdings Henan Co., Ltd. is: wholesale: Chinese patent medicines, Chinese herbal pieces, chemical preparations, chemical raw materials, antibiotics, biochemical drugs, biological products (except vaccines), narcotic drugs, psychotropic drugs (category I), psychotropic drugs (preparations) of category II, in vitro diagnostic reagents, toxic drugs for medical use, protein assimilation preparations and peptide hormone drugs; Category II and III medical devices; Sales: Class I, II and III medical devices, health food, cosmetics, chemical reagents and chemical raw materials (excluding inflammable, explosive and dangerous chemicals); Software development; Information consulting service; Exhibition service; Equipment leasing; Wholesale and retail of daily necessities, disinfection products, communication equipment, electronic products, instruments, electromechanical equipment and accessories, computer software and hardware and accessories; Technical research, technology transfer, technical consultation and technical services of pharmaceutical products; Mechanical and electrical equipment maintenance (except special equipment); Prepackaged foods sales (excluding frozen food); Special food sales (health food, formula food for special medical use, infant formula milk powder, other infant formula food).

See more information and materials of Hebi Branch of Sinopharm Holdings through Aiqi.